Levofloxacina Tecnigen Italia

Levofloxacin, the active ingredient in Levofloxacina Tecnigen Italia, is a fluoroquinolone antibiotic presented as an oral tablet for oral use. It treats a range of bacterial infections including respiratory tract infections, urinary tract infections, and skin infections in adult patients. GNH USA supplies Levofloxacina Tecnigen Italia as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levofloxacina Tecnigen Italia is a fluoroquinolone antibiotic used to treat bacterial infections in several organ systems. - Community‑acquired respiratory tract infection: effective bacterial eradication in acute lung and airway infections. - Acute bacterial sinusitis: clears sinus pathogens and relieves sinus inflammation. - Acute exacerbation of chronic bronchitis: reduces bacterial load and improves breathing function. - Uncomplicated urinary tract infection: eliminates uropathogens causing cystitis. - Skin and soft‑tissue infection: combats Gram‑negative and Gram‑positive skin pathogens. - Prostatitis: penetrates prostatic tissue to treat bacterial inflammation.

Levofloxacina Tecnigen Italia may cause a range of adverse reactions.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Diarrhea: loose stools, sometimes watery. - Headache: transient cranial discomfort. - Dizziness: sensation of light‑headedness. - Abdominal pain: cramping or discomfort in the stomach area. - Rash: mild skin redness or itching.

Serious or Rare Side Effects: - Tendon rupture: sudden tendon pain or loss of function, especially in the Achilles. - QT interval prolongation: risk of cardiac arrhythmias. - Severe allergic reactions: anaphylaxis, swelling, or hives. - Clostridioides difficile infection: severe colitis with watery diarrhea. - Hepatic toxicity: elevated liver enzymes or jaundice. - Peripheral neuropathy: numbness or tingling in extremities.

Before prescribing Levofloxacina Tecnigen Italia, clinicians should consider several safety measures. - Assess renal function: adjust therapy in patients with severe impairment. - Avoid use in patients with known hypersensitivity to fluoroquinolones. - Monitor for tendon pain: discontinue if signs of tendinitis or rupture appear. - Use caution in elderly: higher incidence of CNS effects such as confusion. - Avoid concomitant use with other QT‑prolonging agents: increased arrhythmia risk. - Store at ambient temperature: keep in original container, protect from moisture and light.

Levofloxacina Tecnigen Italia can interact with other medicines, requiring careful management.

Major Interactions (Avoid): - Antacids containing magnesium or aluminum: markedly reduce levofloxacin absorption. - Warfarin: potentiates anticoagulant effect, increasing bleeding risk. - Other fluoroquinolones: additive toxicity, especially tendon and CNS effects.

Moderate Interactions (Monitor Closely): - NSAIDs: may enhance central nervous system stimulation. - Theophylline: levofloxacin can increase serum theophylline levels, risking toxicity. - Diabetes medications: possible alteration of glucose control, requiring monitoring.